PATENT CLAIM ANALYSIS

Application Number: 16097182
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of peanut allergy in humans. Furthermore, the invention provides methods for preventing or treating of peanut allergy in humans.

Claim (Index 5):
The composition of any one of the  claims 3  to  4 , wherein said T helper cell epitope replaces a N-terminal region of said CMV polypeptide, and wherein said N-terminal region of said CMV polypeptide corresponds to amino acids 2-12 of SEQ ID NO:1.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.51852
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15758052', '15520676', '13982986', '11601687', '12443344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7546293614117019
- 35 USC 102 Novelty (BERT): 0.5782828444865276
- Combined Prediction Score: 0.7369947097191845
- Mean Citation Score: 394.389782
- Max Citation Score: 501.40494
- Similarity Product: 398.5013961472357

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test